GeoVax Labs Inc (GOVX)

NASDAQ
2.700
-0.030(-1.10%)
After Hours
2.620
-0.080(-2.963%)
- Delayed Data
  • Volume:
    17,130,957
  • Day's Range:
    2.550 - 2.990
  • 52 wk Range:
    0.551 - 7.460

GOVX Overview

Prev. Close
2.73
Day's Range
2.55-2.99
Revenue
276.9K
Open
2.59
52 wk Range
0.551-7.46
EPS
-2.5
Volume
17,130,957
Market Cap
68.79M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
28,226,841
P/E Ratio
-1.29
Beta
3.19
1-Year Change
-33.58%
Shares Outstanding
24,744,043
Next Earnings Date
10 Nov 2022
What is your sentiment on GeoVax Labs?
or
Market is currently closed. Voting is open during market hours.

GeoVax Labs Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

GeoVax Labs Inc Company Profile

GeoVax Labs Inc Company Profile

Employees
11

GeoVax Labs, Inc. is a clinical-stage biotechnology company. The Company is focused on developing human vaccines and immunotherapies against infectious diseases and cancer using its platforms. Its product pipeline includes ongoing human clinical trials for COVID-19 and head and neck cancer. The Company is developing a number of vaccines and immunotherapies for prevention or treatment of infectious diseases and cancers. The Company’s product candidate includes GEO-CM04S1, GEO-CM02, Gedeptin, MVA-VLP-MUC1, GEO-ZM02, GEO-EM01, GEO-LM01 and GEO-MM02. Its research and development programs include preventive vaccines against Zika Virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa) and malaria, as well as immunotherapies for multiple solid tumors. The Company’s wholly owned subsidiaries include GeoVax, Inc. and Immutak Oncology, Inc.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellNeutralBuySell
Technical IndicatorsSellSellSellBuyStrong Sell
SummaryNeutralSellNeutralBuyStrong Sell